GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Current Accrued Expense

Alto Neuroscience (Alto Neuroscience) Current Accrued Expense : $4.39 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Current Accrued Expense?

Alto Neuroscience's Current Accrued Expense for the quarter that ended in Mar. 2024 was $4.39 Mil.

Alto Neuroscience's quarterly Current Accrued Expense increased from Sep. 2023 ($3.84 Mil) to Dec. 2023 ($4.41 Mil) but then declined from Dec. 2023 ($4.41 Mil) to Mar. 2024 ($4.39 Mil).

Alto Neuroscience's annual Current Accrued Expense increased from Dec. 2021 ($1.21 Mil) to Dec. 2022 ($3.67 Mil) and increased from Dec. 2022 ($3.67 Mil) to Dec. 2023 ($4.41 Mil).

Alto Neuroscience Current Accrued Expense Historical Data

The historical data trend for Alto Neuroscience's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Current Accrued Expense Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Current Accrued Expense
1.21 3.67 4.41

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial 3.67 - 3.84 4.41 4.39

Alto Neuroscience Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Alto Neuroscience Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Current Accrued Expense
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024